Cilazapril anhydrous

This classification denotes an ace inhibitor with the molecular formula C22H31N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8Q9454114Q, chemically known as 6h-pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, 9-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)octahydro-10-oxo-, monohydrate, (1s-(1.alpha.,9.alpha.(r*))), but more generally known as cilazapril anhydrous, which bears US NIH Compound Identifier 56330. European Medicines Agency schedules cilazapril anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06265MIG. Most nations, for tariff purposes, schedule cilazapril anhydrous under HS 29339940. As of Q4 2014, CILAZAPRIL ANHYDROUS remains US FDA's Preferred Term for this commodity. Cilazapril anhydrous bears US NLM identifiers UMLS ID C0886706 and NCI Concept Code C76134. SMILES: CCOC(=O)[C@H](CCC1CCCCC1)N[C@H]2CCCN3CCC[C@H](N3C2=O)C(=O)O.